ClinicalTrials.govpublic full text
Study Comparing Continuous Versus Fixed Duration Therapy With Daratumumab, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
multiple myeloma in relapse, multiple myeloma, relapse, daratumumab,, lenalidomide, dexamethasone, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 899127
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.